New Oncology Pathology Chief Named to New Jersey’s only NCI-Designated Comprehensive Cancer Center

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Nirag Jhala, MD, as chief of the Division of Oncologic Pathology at New Jersey’s leading cancer program and only National Cancer Institute (NCI)-designated Comprehensive Cancer Center.

Breast Cancer Screening in Asian American & Pacific Islander Women in New Jersey

Recently, the United States Preventative Service Task Force released a draft recommendation statement on screening for breast cancer, recommending that all women get screened for breast cancer every other year starting at age 40. Rutgers Cancer Institute expert shares breast cancer data on the AAPI community.

Rutgers is Part of NSF-funded Consortium to Advance Photonics Research and Workforce Development

Rutgers is part of a new federally funded regional collaboration to drive economic and technological advancements in photonics, the National Science Foundation (NSF) announced. The consortium, which includes researchers from Rutgers-Newark and Rutgers-New Brunswick, awarded a development grant from the NSF’s Regional Innovation Economic Engine consortium, led by Princeton University and co-led by Rowan University, with partners throughout New Jersey and neighboring states Delaware, Pennsylvania and New York.

Expert Available for Comment on Black Women, Breast Cancer and Clinical Trials

While there has been an overall decline in breast cancer deaths over the last 30 years, there is a persistent and significant mortality gap between Black women and white women. Black women are also disproportionately affected by more aggressive subtypes of…

Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Radiation Oncology

Dr. Salma Jabbour has been named a Fellow of the American Society of Radiation Oncology (FASTRO). This distinction honors individuals who have made significant contributions to the society and to the field of radiation oncology through research, education, patient care and service to the field.

The Greatest Gift for Mom: Health and Wellness

Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.

Rutgers Cancer Institute of New Jersey Research Leader Elected as a Fellow to the American Association for Cancer Research Academy

Deputy director, chief scientific officer, and associate director for Basic Research at Rutgers Cancer Institute of New Jersey has been elected to the 2021 class of Fellows of the American Association for Cancer Research (AACR) Academy, a prestigious accolade offered only to individuals whose work has had a significant and enduring impact on cancer research.

Identification of Tamoxifen Resistance Markers Can Play Role in Breast Cancer Treatment Planning

In a recent study, researchers from Rutgers University explored the therapeutic response to Tamoxifen, a drug that blocks the activity of estrogen to the breast, in estrogen-receptor (ER) positive breast cancer by using a computational framework to predict treatment resistance based on behavior of molecular pathways.

Exploring the Role of Tumor Suppressor Enhancers in the Development of T-cell Acute Lymphoblastic Leukemia

Researchers from Rutgers Cancer Institute of New Jersey identified a novel enhancer that interacts with a tumor suppressor gene and explored its involvement in normal T-cell development as well as in T-cell acute lymphoblastic leukemia (T-ALL).

Studying Patterns of Relapse in Pediatric Hodgkin Lymphoma using a Response-Based Therapy Approach

Recent research from Rutgers Cancer Institute of New Jersey expert as part of a phase 3 study from the Children’s Oncology Group explores response-based consolidation with modern radiation therapy as safe and effective standard of care for pediatric Hodgkin lymphoma patients. This work is being presented at the Annual Meeting of the American Society for Radiation Oncology (ASTRO) this week.

Rutgers Cancer Institute of New Jersey Awarded $1.6M for Rutgers Youth Enjoy Science (RUYES) Program for Underrepresented Youth and Educators

The Rutgers Youth Enjoy Science (RUYES) program, funded by the National Cancer Institute, will engage underrepresented minority undergraduate and high school students in cutting-edge cancer research, curriculum support, and professional development activities.

Presence of Cumulative Physiological Stress Prior to Diagnosis Linked to Poor Health-Related Quality of Life in African American and Black Breast Cancer Survivors

Rutgers University investigators conducted a study to determine the association of pre-diagnostic allostatic load, which is a composite measure of cumulative physiological stress and wear and tear on the body, with health-related quality of life in African American and Black survivors of breast cancer.

$50K Grant Supports Exploration of Treatment for Liver Cancer

Incidence and mortality of hepatocellular carcinoma (HCC), a common type of liver cancer, is increasing in the United States. Rutgers Cancer Institute of New Jersey experts have received a $50,000 award through the Translational Research Pilot Award Program that will support the examination of how a drug combination impacts the growth of both human HCC cancer cells and tumors in laboratory models, with the goal of identifying a new treatment for patients with this disease.

Thyroid Cancer: Small Gland, Big Impact

The thyroid is a key part of the endocrine system, a small gland at the base of your neck that produces a hormone that helps control your body’s metabolism. One of the most common and treatable cancers in the United States is thyroid cancer. Rutgers Cancer Institute expert discusses research and treatment for this disease.